Continuum Advisory’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-61
Closed -$4.46K 860
2025
Q1
$4.46K Buy
61
+25
+69% +$2.07K ﹤0.01% 1136
2024
Q4
$2.98K Sell
36
-3
-8% -$237 ﹤0.01% 1287
2024
Q3
$3.16K Buy
39
+9
+30% +$635 ﹤0.01% 1288
2024
Q2
$2.06K Hold
30
﹤0.01% 1293
2024
Q1
$1.93K Buy
+30
New +$1.61K ﹤0.01% 1310

Other funds holding GMED

Continuum Advisory's GMED Position: Q2 2025 in Review

Continuum Advisory sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 61 shares — an estimated $4.46K sold.

Continuum Advisory first reported a position in GMED in Q1 2024 and held it in 5 quarters. The position peaked at $4.46K in Q1 2025. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Continuum Advisory reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 61 Globus Medical shares in Q2 2025, an estimated $4.46K.
  • Continuum Advisory first reported a position in Globus Medical in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Globus Medical position peaked at $4.46K in Q1 2025.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.